rafaeltoral said...
Anyway, even with everything I'm doing I'm still slipping back into a flare. So, my next step is to quit everything I'm doing and start Remicade or Entyvio. What do those with experience with either think? What side effects should I look our for?
First, I wouldn't quit everything you're currently doing, they're working but not enough by themselves and need a "helping hand" added to them.
Either biologic has about
the same odds of success (about
65% respond to them and have improvements within their UC symptoms). I'll describe some pros and cons of both and you can check with your doctor and insurance and see what makes the most sense. For me personally, I've been on Remicade since 2012 and it has worked well for me and given me a remission with no side effects. Some here are on entyvio and it has worked well for them as well.
Remicade is the hare and Entyvio is the turtle in the rabbit/turtle race. You'll get a response in 3-6 weeks or less from Remicade. Entyvio can take 12-14 weeks or less for a response. If your flare is mild then Entyvio is fine, for severe flares Remicade would be the recommendation.
Remicade was the 1st biologic approved for treating UC, has a long safety record and many have been on it for 8-10 years or more. Remicade is systematic in suppressing your immune system, and infections requiring antibiotics like bronchitis, sinusitis, UTI and others are going to hit you harder and last longer. Entyvio is a site-specific-immunomodulator affecting only your digestive tract, so systematic infections are less of a concern (however, you still have increased risk of GI-based things like stomach flu), it's a newer more advanced medication (should be safer but there isn't a decades long safety record behind it).
Some insurance policies require you to first try a tnf-alpha-blocker class of biologics (remicade/humira/simponi) before going to entvyio, as the older tnf-based medications are cheaper. If they require one before the other than that makes your choice easy.
Both medications have patient copay assistance programs that are great. I've been using RemiStart for years and it lowers my out-of-pocket cost to $5, every 8-weeks. Entyvio has a similar program available. The billing is more complex, both are IV-infusions given as a hospital-outpatient procedure. You might have hospital deductables or copays that are different than what you have now for oral-mesalamine.
Remicade patient assistance:
/remicade.janssencarepathsavings.com/#/app/homeEntyvio:
/www.entyvio.com/financial-support